课题基金 / 基金详情

STRUCTURE-ACTIVITY RELATIONSHIPS OF ALKANEDIAMINES HAVING ANTI-MULTIDRUG RESISTANT ACTIVITY

STRUCTURE-ACTIVITY RELATIONSHIPS OF ALKANEDIAMINES HAVING ANTI-MULTIDRUG RESISTANT ACTIVITY
具有抗多重耐药活性的链二胺的构效关系
批准号:
06672241
负责人:
SAWANISHI Hiroyuki
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

SAWANISHI Hiroyuki的其他基金

相似基金

相关文献

中文摘要
翻译
多药耐药是肿瘤化疗的主要障碍。为了获得有效的多药耐药调节剂,我们合成了一系列的二胺,二甲酰胺,和二磺酰胺化合物与终端苯,甲基或氯取代的苯环在两个末端,并检查长春碱的积累在多药耐药小鼠白血病P388/ADR细胞的效果。这些化合物的药效一般为二磺酰胺类>二胺类>二甲酰胺类。在其结构中具有末端甲基或氯取代的苯环的N-甲基化的二胺和二磺酰胺化合物也显示出相当有效的功效。基于这些发现,我们合成了一种新的二磺酰胺化合物,1,2,3,4,5,6-六氢-2,5-二(对甲苯磺酰基)苯并[2,5]二氮杂环辛,并且该化合物在体外有效地逆转多药耐药性。此外,1,3,5-三氮杂环庚烷的合成和检查逆转P-糖蛋白依赖的多药耐药。大多数化合物能增加耐药小鼠白血病P388/ADR细胞对长春碱的摄取,但不影响长春碱在P388/S细胞中的蓄积。1,5-二苄基-1,3,5-三氮杂环庚烷类化合物增加长春碱蓄积的效果顺序为2,4-二硫代>2-氧代-4-硫代=4-(甲硫基)-2-氧代> 2,4-二氧代。当苄基转化为氯苄基时,效力进一步增加。在这些化合物中,1,5-二(4-氯苄基)-1,5,6,7-四氢-4-甲硫基)-2H-1,3,5-三氮杂卓-2-酮增强长春碱、阿霉素和丝裂霉素C对P388/ADR细胞的体外细胞生长抑制作用,并且与长春碱联合治疗比单独长春碱更延长P388/ADR荷瘤小鼠的寿命。
英文摘要
Multidrug resistance is a major obstacle in cancer chemotherapy. To obtain potent multidrug resistance modulators we synthesized a series of diamine, dicarboxamide, and disulfonamide compounds with terminal benzene, methyl- or chloro-substituted benzene rings at both termini and examined the effect on vinblastine accumulation in multidrug-resistant mouse leukemia P388/ADR cells. The efficacy of these compounds was generally in the order of disulfonamides>diamines>dicarboxamides. N-Methylated diamine and disulfonamide compounds having terminal methyl- or chloro-substituted benzene ring in their structure also showed rather potent efficacy. From these findings, we synthesized a novel disulfonamide compound, 1,2,3,4,5,6-hexahydro-2,5-bis (p-toluenesulfonyl) benzo [2,5] diazicine, and this compound potently reversed multidrug-resistance in vitro. Furthermore, 1,3,5-triazacycloheptanes were synthesized and examined for reversal of P-glycoprotein-dependent multidrug resistance. Most of these compounds increased the intracellular uptake of vinblastine in multidrug-resistant mouse leukemia P388/ADR cells without influence upon the vinblastine accumulation in P388/S cells. The efficacy of 1,5-dibenzyl-1,3,5-triazacycloheptanes in increasing the vinblastine accumulation was in the order of 2,4-dithioxo>2-oxo-4-thioxo=4- (methylthio) -2oxo>2,4-dioxo. The efficacy was further increased when the benzyl group was converted to a chlorobenzyl group. Among these compounds, 1,5-bis (4-chlorobenzyl) -1,5,6,7-tetrahydro-4-methylthio ) -2H-1,3,5-triazepin-2-one increased the in vitro cell growth-inhibitory effect of vinblastine, adriamycin, and mitomycin C on P388/ADR cells and prolonged the life span of P388/ADR-bearing mice in combined therapy with vinblastine more than vinblastine alone.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
HIROYUKI,SAWANISHI: "Novel inhibitors for multidrug resistance : 1,3,5-triazacycloheptanes" J Med Chem. 38. 5066-5070 (1995)
HIROYUKI,SAWANISHI:“新型多重耐药抑制剂:1,3,5-三氮杂环庚烷”J Med Chem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
HIROYUKI,SAWANISHI: "Structure-activity relationships of diamines, dicarboxamides, and disulfonamides on vinblastine accumulation in P388/ADR cells" Chem Pharm Bull. 42. 1459-1462 (1994)
HIROYUKI,SAWANISHI:“二胺、二甲酰胺和二磺酰胺对 P388/ADR 细胞中长春花碱积累的结构活性关系”Chem Pharm Bull。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H. Sawanishi: "Novel inhibitors for moltidrug resistance: 1,3,5-triazacyoloheptanes" J Med Chem. 38. 5066-5070 (1995)
H. Sawanishi:“新型耐药抑制剂:1,3,5-三氮杂环庚烷”J Med Chem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
HIROYUKI,SAWANISHI: "Structure-activity relationships of diamines,dicarboxamides,and disulfonamides on vinblastine accumulation in P388/ADR cells" Chem Pharm Bull. 42. 1459-1462 (1994)
HIROYUKI,SAWANISHI:“二胺、二甲酰胺和二磺酰胺对 P388/ADR 细胞中长春花碱积累的结构活性关系”Chem Pharm Bull。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Structure-activity relationship of triazacycloalkanes for reversal of antitumor multidrug resistance
  • 批准号:
    08672570
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.34万
  • 财政年份:
    1996
  • 负责人:
    SAWANISHI Hiroyuki
  • 依托单位:
海外基金